Authors: Miconnet, I Coste, I Beermann, F Haeuw, JF Cerottini, JC Bonnefoy, JY Romero, P Renno, T

Citation: I. Miconnet et al., Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTLinduction, J IMMUNOL, 166(7), 2001, pp. 4612-4619

Authors: Jeannin, P Renno, T Goetsch, L Miconnet, I Aubry, JP Delneste, Y Herbault, N Baussant, T Magistrelli, G Soulas, C Romero, P Cerottini, JC Bonnefoy, JY

Citation: P. Jeannin et al., OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway, NAT IMMUNOL, 1(6), 2000, pp. 502-509

Authors: Valmori, D Levy, F Miconnet, I Zajac, P Spagnoli, GC Rimoldi, D Lienard, D Cerundolo, V Cerottini, JC Romero, P

Citation: D. Valmori et al., Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue, J IMMUNOL, 164(2), 2000, pp. 1125-1131

Authors: Miconnet, I Servis, C Cerottini, JC Romero, P Levy, F

Citation: I. Miconnet et al., Amino acid identity and/or position determines the proteasomal cleavage ofthe HLA-A0201-restricted peptide tumor antigen MAGE-3(271-279), J BIOL CHEM, 275(35), 2000, pp. 26892-26897

Authors: Men, Y Miconnet, I Valmori, D Rimoldi, D Cerottini, JC Romero, P

Citation: Y. Men et al., Assessment of immunogenicity of human melan-A peptide analogues in HLA-A0201/K-b transgenic mice, J IMMUNOL, 162(6), 1999, pp. 3566-3573